Company page

Promis Neurosciences Inc.

Promis Neurosciences Inc. is a public company traded under the ticker PMN in the American market. With a market capitalization of approximately $109.4 million, the company focuses on developing innovative therapies for neurodegenerative diseases. Promis aims to address significant unmet medical needs in this area through its research and development efforts.